Arylsulfonamides as a new class of cannabinoid CB1 receptor ligands: Identification of a lead and initial SAR studies

Bioorganic & Medicinal Chemistry Letters
2007.0

Abstract

High-throughput screening of the UCB sample collection identified the piperidinyl-sulfonyl benzoic ester 1 as a novel agonist for CB(1) receptor with nanomolar affinity. We report here the pharmacological profile of compound 1 as well as preliminary biological activities in pain model. Diverse close analogs of 1 were purchased and the structure-affinity relationships among this novel class are discussed.

Knowledge Graph

Similar Paper

Arylsulfonamides as a new class of cannabinoid CB1 receptor ligands: Identification of a lead and initial SAR studies
Bioorganic & Medicinal Chemistry Letters 2007.0
Novel sulfenamides and sulfonamides based on pyridazinone and pyridazine scaffolds as CB 1 receptor ligand antagonists
Bioorganic & Medicinal Chemistry 2018.0
Two distinct classes of novel pyrazolinecarboxamides as potent cannabinoid CB1 receptor agonists
Bioorganic & Medicinal Chemistry Letters 2010.0
Sulfamoyl benzamides as novel CB2 cannabinoid receptor ligands
Bioorganic & Medicinal Chemistry Letters 2008.0
2-Arylimino-5,6-dihydro-4H-1,3-thiazines as a new class of cannabinoid receptor agonists. Part 1: Discovery of CB2 receptor selective compounds
Bioorganic & Medicinal Chemistry Letters 2007.0
Novel indole and azaindole (pyrrolopyridine) cannabinoid (CB) receptor agonists: Design, synthesis, structure–activity relationships, physicochemical properties and biological activity
European Journal of Medicinal Chemistry 2011.0
Discovery of N-(3-(morpholinomethyl)-phenyl)-amides as potent and selective CB2 agonists
Bioorganic & Medicinal Chemistry Letters 2009.0
Design, synthesis, binding, and molecular modeling studies of new potent ligands of cannabinoid receptors
Bioorganic & Medicinal Chemistry 2007.0
Novel sterically hindered cannabinoid CB1 receptor ligands
Bioorganic & Medicinal Chemistry 2008.0
Design, synthesis, and structure–activity relationship study of bicyclic piperazine analogs of indole-3-carboxamides as novel cannabinoid CB1 receptor agonists
Bioorganic & Medicinal Chemistry Letters 2010.0